Literature DB >> 19079205

Evolving immunosuppressive microenvironment during human cervical carcinogenesis.

A Kobayashi1, V Weinberg, T Darragh, K Smith-McCune.   

Abstract

Chronic infection with human papillomavirus (HPV) can result in cervical cancer. To understand how HPV escapes immune eradication, we examined biophenotypes of immune cells in human normal cervix, cervical intraepithelial neoplasia (CIN), and cancer. Expression and cellular localization of Forkhead box protein-3 (FOXP3), indolamine 2,3-dioxygenase (IDO), interleukin (IL)-10, and interferon (IFN)-gamma were examined by immunofluorescence and immunohistochemistry. Mean cell densities of stromal FOXP3+ cells, IDO+ cells, IL-10+ cells, CD1a+ cells, and macrophages significantly increased from normal cervix to cancer, whereas densities of IFN-gamma+ and MMP-9+ cells increased from normal cervix to CIN but decreased in cancer. Flow cytometry confirmed significant elevation of cervical T cells expressing IFN-gamma and transforming growth factor-beta in CIN compared with normal cervix. Upon activation, a significantly increased proportion of cervical T cells expressed IFN-gamma in CIN than normal. A unique subset of morphologically immature stromal dendritic cells expressing IL-10 and IDO was more numerous in cancer than in normal cervix and CIN. The potentially suppressive immune milieu in the cervix may be permissive of HPV-associated cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079205     DOI: 10.1038/mi.2008.33

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  63 in total

Review 1.  Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations.

Authors:  Teresa C Longoria; Krishnansu S Tewari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.

Authors:  Fernando Cezar-Dos-Santos; Rodolfo Sanches Ferreira; Nádia Calvo Martins Okuyama; Kleber Paiva Trugilo; Michelle Mota Sena; Érica Romão Pereira; Ana Paula Lombardi Pereira; Maria Angelica Ehara Watanabe; Karen Brajão de Oliveira
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-08       Impact factor: 4.553

3.  Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Authors:  Mark E Scott; Yurii B Shvetsov; Pamela J Thompson; Brenda Y Hernandez; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Dien D Vo; Anna-Barbara Moscicki; Marc T Goodman
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

4.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in cervical carcinoma patients.

Authors:  Liangliang Wu; Hongyu Liu; Hongchuan Guo; Qiong Wu; Songyan Yu; Yuanyuan Qin; Gang Wang; Qiyan Wu; Rong Zhang; Lingxiong Wang; Lijun Zhang; Chunxi Liu; Shunchang Jiao; Tianyi Liu
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

5.  Polymorphisms in immune mediators associate with risk of cervical cancer.

Authors:  Zhengyan Zhang; Samantha Fye; Ingrid B Borecki; Janet S Rader
Journal:  Gynecol Oncol       Date:  2014-08-12       Impact factor: 5.482

6.  Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene.

Authors:  Pavel Gabriel; Katarina Babiarova; Kamila Zurkova; Jitka Krystofova; Petr Hainz; Luda Kutinova; Sarka Nemeckova
Journal:  Viral Immunol       Date:  2012-10       Impact factor: 2.257

7.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

8.  Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.

Authors:  Karen K Smith-McCune; Stephen Shiboski; Mike Z Chirenje; Tsitsi Magure; Jennifer Tuveson; Yifei Ma; Maria Da Costa; Anna-Barbara Moscicki; Joel M Palefsky; Rudo Makunike-Mutasa; Tsungai Chipato; Ariane van der Straten; George F Sawaya
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

9.  Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.

Authors:  Takashi Iwata; Takuma Fujii; Kenji Morii; Miyuki Saito; Juri Sugiyama; Hiroshi Nishio; Tohru Morisada; Kyoko Tanaka; Tomonori Yaguchi; Yutaka Kawakami; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-03-01       Impact factor: 3.402

10.  In vivo effects of nonoxynol-9 on endometrial immune cell populations.

Authors:  Lisa Rahangdale; Ruth M Greenblatt; Jean Perry; Teresa M Darragh; Akiko Kobayashi; Karen K Smith-McCune
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.